Nordic Pharma Presents Data and Patient Experience Study for Lacrifill Canalicular Gel at ASCRS

Nordic Pharma will be presenting recently published patient data and patient experience study for Lacrifill Canalicular Gel, a novel therapy for dry eye symptoms, during the ASCRS annual meeting in Los Angeles.

The April issue of Cataract & Refractive Surgery Today (CRST) features the “Improved Visual Outcomes With Lacrifill Canalicular Gel-Assisted Ocular Surface Optimization” case study by Neel Desai, MD, and Subhashini Chandrasekaran, MD, which illustrates how lacrimal occlusion using Lacrifill Canalicular Gel for dry eye, can markedly improve visual acuity and optical quality in a patient with fluctuating vision after cataract surgery.

The May issue of CRST will contain results from a patient experience survey conducted with first time and repeat Lacrifill Canalicular Gel patients of MDs and ODs, where 98.11% of respondents answered “yes” when asked if they will come back in the future for another dose of Lacrifill Canalicular Gel. 

Attendees can visit the Nordic Pharma booth #717 at ASCRS where they will have the opportunity to recognize the heroic efforts of firefighters during the recent California wildfires. Nordic Pharma is providing a QR code at their booth to make donations to the Los Angeles Fire Department Foundation, a portion of which Nordic Pharma will match to increase the impact. https://supportlafd.kindful.com/?campaign=1358405